Scientists test new Tumor-Tracking tracer in patients
NCT ID NCT05989997
Summary
This was a first-in-human study to test a new radioactive imaging agent called 68Ga-NOTA-SNA002. It involved 17 adult patients with various solid tumors to see if the agent was safe and to measure how much radiation the body absorbs from it. The main goal was to understand how this tracer moves through and collects in the body using PET scans, not to treat the cancer.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for SOLID TUMOR are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Zhongshan Hospital Affiliated to Fudan University
Shanghai, China
Conditions
Explore the condition pages connected to this study.